Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04275934 · ClinicalTrials.gov registry record

Blood Pressure First Medication Therapy Management

A clinical trial of Hypertension and Cardiovascular Diseases, sponsored by American Pharmacists Association Foundation.

Completed
Registry status
27
Enrollment target
1
Study location

NCT04275934 is a study of Hypertension and Cardiovascular Diseases that has completed, run by American Pharmacists Association Foundation. The registered enrollment target is 27 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04275934, a study of Hypertension and Cardiovascular Diseases, has completed, sponsored by American Pharmacists Association Foundation.

COMPLETED
Registry status
27 participants
Enrollment target
1
Study location

Study Summary

The primary objective of this project is to improve the health status of participants through pharmacist-delivered blood pressure control programs that demonstrate value to employers and justify adoption, sustainability and scalability of these programs.

Interventions

  • BEHAVIORAL Health Management; Blood Pressure

Study Locations (1)

Georgia

  • Woodstock Pharmaceutical & Compounding Center Inc. - Woodstock

Trial Details

FieldValue
Enrollment Target 27 participants
Start Date 2020-02-06
Est. Completion 2020-12-31

What the Registry Record Tells You About NCT04275934

The ClinicalTrials.gov registry entry for NCT04275934 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (99% lower). The listed sponsor is American Pharmacists Association Foundation, which has 5 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Hypertension appearing as the primary indexed condition, and to 1 intervention - of which Health Management; Blood Pressure is the first listed.

NCT04275934 reports 1 study location spanning 1 distinct geographic area - top geographies include Georgia.

Frequently Asked Questions

What is clinical trial NCT04275934 about?

NCT04275934 is a clinical study titled "Blood Pressure First Medication Therapy Management". The primary objective of this project is to improve the health status of participants through pharmacist-delivered blood pressure control programs that demonstrate value to employers and justify adoption, sustainability and scalability of these programs.

What is the current status of trial NCT04275934?

This trial is currently completed. The enrollment target is 27 participants. The study started on 2020-02-06. Estimated completion is 2020-12-31.

What conditions does trial NCT04275934 study?

This clinical trial studies the following conditions: Hypertension, Cardiovascular Diseases, Blood Pressure.

What interventions are being tested in trial NCT04275934?

The interventions under investigation include: Health Management; Blood Pressure (BEHAVIORAL).

Who is sponsoring clinical trial NCT04275934?

This trial is sponsored by American Pharmacists Association Foundation, which has 5 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04275934 being conducted?

This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.